GLG

January is a developer of a data-driven financial platform that focuses on providing end-to-end resolution services for delinquent and charged-off consumer loans. The platform aims to build and enforce trust in consumer finance by addressing the challenges faced by borrowers in delinquency and default, such as harassment, hidden fees, and damaged credit scores. At the same time, it helps creditors recover lost funds while mitigating compliance and operational risks. By utilizing technology, January offers a streamlined and effective resolution process that caters to the unique financial situations and preferences of borrowers, ultimately fostering a more trustworthy relationship between borrowers and creditors.

Imbellus, Inc. is a Los Angeles-based company founded in 2015 that specializes in developing simulation-based cognitive assessments to measure human potential and deep thinking skills. By focusing on how individuals think rather than what they know, Imbellus aims to transform standardized testing practices, potentially replacing traditional assessments like the SAT and ACT. The company's innovative approach integrates game design principles with cognitive science to create engaging problem-solving scenarios that reflect real-world situations. Additionally, Imbellus collaborates with corporate and government partners to enhance hiring, upskilling, and retention strategies. The team comprises experts in learning science, game development, art, data science, and artificial intelligence, reflecting a multidisciplinary approach to modern assessment challenges.

Celmatix Inc. is a personalized medicine company dedicated to advancing women's health, particularly in the areas of reproductive health and fertility. Founded in 2009 and based in New York, the company has developed innovative solutions such as POLARIS, a web-based analytics platform that assesses a woman's likelihood of success with various fertility treatments based on her clinical metrics. Additionally, Celmatix offers NOVA, a patient portal designed to enhance the patient experience within clinics. By leveraging predictive analytics and genomics, the company enables women to make informed decisions regarding their fertility while equipping healthcare providers with data-driven tools for improved patient care. Celmatix has also established a strategic alliance with Evotec to further its research and development endeavors.

Ushi is a private business social networking platform connecting China's influential professionals and entrepreneurs via mobile phones and PCs. Ushi makes it easier to find new customers, partners, employees, jobs, and experts, and enables members to share and discuss information. 优士 (yōushì) means 'outstanding professionals' in Chinese, with a double meaning of 'competitive advantange'. Ushi is focused on helping its members to expand and maximize the value of their professional networks, to achieve greater success. Shanghai-based Ushi was founded by 100 Charter Members who are successful business leaders in China, including partners of the most famous VC firms, investment banks, law firms, and accounting firms, as well as CEOs of advertising agencies, luxury brands, and leading companies in Internet, mobile, renewable energy, travel, hotel, real estate and other industries. As such, Ushi aims to be China's top platform for business networking, featuring the highest quality community and opening up the highest quality opportunities for members. http://www.Ushi.com

Kyruus, Inc. is a Boston-based company that develops web-based software solutions aimed at optimizing physician networks for hospitals, health systems, and life science companies. Founded in 2010, Kyruus offers a suite of analytically driven products designed to enhance provider search and scheduling, ensuring that patients are matched with the most suitable healthcare providers. Key offerings include Kyruus Passport, which allows physicians to track their activity and productivity, and Kyruus Profiles, which enables administrators to analyze physician performance metrics. Additionally, the company provides Kyruus MDSeekyr, a platform for identifying high-value providers, and Kyruus Insight Reports, which help executives evaluate network activity and performance trends. By leveraging a proprietary provider data management platform, Kyruus enhances patient engagement and aligns provider supply with patient demand, ultimately improving the overall healthcare experience. Kyruus also maintains offices in San Francisco and New York.